CHATSWORTH, Calif., June 2, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chairman, President and Chief Executive Officer Cesar M. Garcia will present an overview of the Company at the 6th Annual Craig-Hallum Institutional Investor Conference at 2:00 p.m. Central time on Thursday, June 11, 2009 at the Radisson Plaza Hotel in Minneapolis, Minnesota.
More than 50 companies from a variety of industries, including medical device manufacturers, will participate in the conference sponsored by Craig-Hallum, an institutional equity and investment-banking firm. During the conference, executives from each company will participate in private one-on-one sessions with select institutional investors. The conference is only for clients of Craig-Hallum and the sessions will not be webcast.
About IRIS International
IRIS International is a leading global in vitro diagnostics company focused on products that analyze particles and living cell forms and structures, or morphology of a variety of body fluids. The Company's products leverage its strengths in flow imaging technology, particle recognition and automation to bring efficiency to hospital and commercial laboratories. The initial applications for its technology have been in the urinalysis market and the Company is the leading worldwide provider of urine microscopy systems, with an installed base of more than 2,230 systems in more than 50 countries. For more information visit www.proiris.com.